Kalaris Therapeutics (KLRS) Assets (2019 - 2020)
Kalaris Therapeutics (KLRS) has 2 years of Assets data on record, last reported at $393.7 million in Q3 2020.
- For Q3 2020, Assets changed N/A year-over-year to $393.7 million; the TTM value through Sep 2020 reached $393.7 million, changed N/A, while the annual FY2019 figure was $139.4 million, N/A changed from the prior year.
- Assets reached $393.7 million in Q3 2020 per KLRS's latest filing, up from $117.8 million in the prior quarter.
- Across five years, Assets topped out at $393.7 million in Q3 2020 and bottomed at $117.8 million in Q2 2020.